To evaluate the clinical outcome of microsurgery, gamma-knife radiosurgery, and conservative treatment, we retrospectively reviewed 96 consecutive patients with cerebral arteriovenous malformation (AVM) in the thalamus and basal ganglia, treated at our institute between 1971 and 1995.
Among 16 patients treated conservatively, 10 patients (62.5%) bled during the follow up period (2-11 years). Eight of these 10 patients with a history of bleeding had rebleeding. The mortality of hemorrhage was 60.0% and morbidity was 20%.
In 15 patients who underwent surgical resection, no patients showed deterioration of pre-existing hemiparesis after surgery, while newly developed mild hemiparesis was recorded in 4 of 7 patients who showed no paresis before surgery. Speech dysfunction was persisted after resection in only 1 of 6 patients with dominant side AVM. Visual field defect permanently persisted after surgery in 5 patients.
Sixty patients underwent gamma knife radiosurgery. The actuarial obliteration rate of AVM was 28.8% at 1 year, and 85.7% at 2.5 years. Radiation induced brain edema was observed in 12 patients (20.0%). However, permanent neurological deterioration after radiosurgery was observed in only 3 patients (5.0%), who showed deterioration of pre-existing hemiparesis. Hemorrhage during the latency interval occurred in 3 patients (5.0%). In 1 patient, deterioration of hemiparesis associated with optic visual loss was permanently recorded after hemorrhage.
Patients' final outcome after surgery was good except for 1 patient who suffered intracranial hemorrhage during rehabilitation. No patient experienced a deterioration in activity of daily living after gamma knife radiosurgery, except for 1 patient who suffered rebleeding. As a result, overall management outcome for AVM in the thalamus and basal ganglia improved after gamma knife installation, because inoperable AVMs were successfully treated radiosurgically.
In conclusion, prognosis of patients with a history of hemorrhage was poor if conservatively treated. Such patients should be treated to prevent further bleeding. Patients with hematoma cavity around the nidus who present hemiparesis should be surgically extirpated, especially if the nidus is located in the thalamus and caudate nucleus. Patients without a clinical history of hemorrhage, or patients without neurological deficits should be radiosurgically treated, if the nidus is small. Patients with large nidus and a history of hemorrhage should be first treated with embolization, and then treated by either surgical resection or irradiation.
View full abstract